BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 4404282)

  • 1. Inhibition of the graft-versus-host reaction. I. Reduction of the graft-versus-host potential of mouse spleen cells (with a sparing of stem cells) by treatment with antilymphocyte globulin-derived Fab fragments.
    Gallagher MT; Richie ER; Heim LR; Judd KP; Trentin JJ
    Transplantation; 1972 Nov; 14(5):597-602. PubMed ID: 4404282
    [No Abstract]   [Full Text] [Related]  

  • 2. Prevention of graft-versus-host disease by Fab fragments derived from ALG.
    Richie ER; Gallagher MT; Trentin JJ
    Transplant Proc; 1973 Mar; 5(1):873-6. PubMed ID: 4144467
    [No Abstract]   [Full Text] [Related]  

  • 3. Inhibition of the graft-versus-host reaction. III. Altered in vivo distribution of spleen cells pretreated with Fab fragments of antithymocyte globulin.
    Richie ER; Monié HJ; Trentin JJ; Taub RN
    Transplantation; 1975 Feb; 19(2):115-20. PubMed ID: 235162
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antilymphocytic antibodies and marrow transplantation. IV. Comparison of the effects of antibody fragments directed against immunoglobulin or lymphocyte antigens on acute secondary disease.
    Rodt H; Therfelder S; Eulitz M
    Exp Hematol; 1974; 2(4):195-203. PubMed ID: 4156327
    [No Abstract]   [Full Text] [Related]  

  • 5. Inhibition of allograft reactivity in vitro and in vivo, by Fab fragments obtained from ALG.
    Gallagher MT; Richie ER; Trentin JJ
    Transplant Proc; 1973 Mar; 5(1):869-72. PubMed ID: 4144466
    [No Abstract]   [Full Text] [Related]  

  • 6. Interaction of anti-thymocyte serum with hematopoietic stem cells. I. Effects in vitro and in vivo.
    Mookerjee BK; Azzolina L; Poultar L
    J Immunol; 1974 Feb; 112(2):822-9. PubMed ID: 4149885
    [No Abstract]   [Full Text] [Related]  

  • 7. Prevention of acute graft-versus-host (GVH) mortality with spleen-absorbed antithymocyte globulin (ATG).
    Trentin JJ; Judd KP
    Transplant Proc; 1973 Mar; 5(1):865-8. PubMed ID: 4540468
    [No Abstract]   [Full Text] [Related]  

  • 8. [Suppression of interferon synthesis during the "graft-versus-host" reaction in F1(CBAXC57BL/6) mice].
    Mentkevich LM; Shcheglovitova ON; Gulianskii LN; Shevelev AS
    Biull Eksp Biol Med; 1976 Sep; 82(9):1098-1100. PubMed ID: 11014
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interaction of anti-thymocyte serum with haematopoietic stem cells. II. Stimulation of colony formation in vitro.
    Mookerjee BK; Poulter L
    Immunology; 1974 Oct; 27(4):601-7. PubMed ID: 4140146
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Active enhancement of tissue allografts with antilymphocyte serum and bone marrow.
    Monaco AP; Liegeois A; Wood ML; Clark AW
    Adv Nephrol Necker Hosp; 1975; 5():135-72. PubMed ID: 242206
    [No Abstract]   [Full Text] [Related]  

  • 11. Dichotomy and improved specificity of immunosuppressive effect of anti-thymocyte globulin.
    Judd KP; Bryant CJ; Trentin JJ
    J Immunol; 1972 May; 108(5):1461-4. PubMed ID: 4555122
    [No Abstract]   [Full Text] [Related]  

  • 12. An investigation into the influence of a graft-versus-host reaction, induced by parent line cells, on the growth of lymphoma transplants in F1 hybrid mice.
    Palmer AM; Symes MO
    Folia Biol (Praha); 1974; 20(1):26-35. PubMed ID: 4154872
    [No Abstract]   [Full Text] [Related]  

  • 13. Hemopoietic inductive envirnment necessary for an early stage in differentiation of thymic immune cells: effect of antilymphocytic serum.
    Bennett M
    J Cell Physiol; 1972 Apr; 79(2):309-16. PubMed ID: 4402104
    [No Abstract]   [Full Text] [Related]  

  • 14. Inhibition of the graft-versus-host reaction. II. Prevention of acute graft-versus-host mortality by Fab fragments of antilymphocyte globulin.
    Richie ER; Gallagher MT; Trentin JJ
    Transplantation; 1973 May; 15(5):486-91. PubMed ID: 4145551
    [No Abstract]   [Full Text] [Related]  

  • 15. The ability of cell fractions of mouse spleen to repopulate the hemopoietic tissue and to mount graft-versus-host reaction.
    Blazi-Poljak M; Boranić M
    Exp Hematol; 1975 Apr; 3(2):85-93. PubMed ID: 237767
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic resistance in the graft-versus-host reaction.
    Sula K; Nouza K
    Exp Clin Immunogenet; 1984; 1(3):175-84. PubMed ID: 6101099
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pretreatment with antilymphocyte globulin and donor cells on graft prolongation in an experimental model and some observations on graft-versus-host reaction.
    Pegrum GD; Williams G; Markwick J; Barnes RM
    Postgrad Med J; 1976; 52(5 Suppl):47-50. PubMed ID: 11454
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bone marrow transplantation across the major histocompatibility barrier in specific-pathogen-free mice: effects of intact versus T cell-depleted bone marrow on the expression of anti-host reaction in the recipient spleens.
    Muto M; Sado T; Aizawa S; Kamisaku H; Kubo E
    J Immunol; 1981 Dec; 127(6):2421-5. PubMed ID: 6457876
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of graft-versus-host disease (GVHD) on host hematopoietic progenitor cells is mediated by Fas-Fas ligand interactions but this does not explain the effect of GVHD on donor cells.
    Iwasaki T; Hamano T; Saheki K; Kuroiwa T; Kataoka Y; Takemoto Y; Ogata A; Sugihara A; Terada N; Fujimoto J; Kakishita E
    Cell Immunol; 1999 Oct; 197(1):30-8. PubMed ID: 10555993
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclophosphamide-induced graft-versus-host immunotolerance.
    Van Winkle MG
    J Reticuloendothel Soc; 1971 Nov; 10(5):403-17. PubMed ID: 4399566
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.